Editas Medicine, Inc.EDITNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
3.24
↓ 96% below average
Average (9y)
84.07
Historical baseline
Range
High:398.85
Low:3.24
CAGR
-41.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 3.24 | -67.1% |
| 2023 | 9.85 | -68.1% |
| 2022 | 30.90 | -56.0% |
| 2021 | 70.28 | +55.2% |
| 2020 | 45.29 | -37.2% |
| 2019 | 72.09 | +114.9% |
| 2018 | 33.55 | -62.8% |
| 2017 | 90.26 | +4.5% |
| 2016 | 86.39 | -78.3% |
| 2015 | 398.85 | - |